Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis: a case report Dr Kartikeya Kohli21 April 2025 3:30 AMSemaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report published in the BMC...
New Dietary Recommendation for Managing Gastrointestinal Issues Treated with GLP-1 Receptor Agonists Dr Jeegar Dattani1 Feb 2025 11:21 AMA recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for individuals using GLP-1...
Oral Semaglutide Lowers Cravings and Improves Metabolic Health in Type 2 Diabetes Patients: Study Dr Riya Dave1 Feb 2025 3:45 AMA new study published in the journal Diabetes & Vascular Disease Research has found that oral semaglutide reduces total energy intake and changes...
Add on SGLT-2 Inhibitors may help manage recurrence of nephrolithiasis and Gout in kidney stone patients, suggests study Medha Baranwal5 Nov 2024 10:00 PMUSA: A recent study has shed light on the potential advantages of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients experiencing...
Bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection suggests Cleveland Clinic study Dr. Kamal Kant Kohli24 Sept 2024 2:00 AMA Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a...
GLP-1 receptor agonist drugs effective but come with complex concerns shows Research Dr. Kamal Kant Kohli12 Jun 2024 3:15 AMDrugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight...
Novel, oral GLP-1 receptor agonist significantly reduced HbA1c and weight in type 2 diabetes patients: Phase IIa trial Medha Baranwal22 Dec 2023 10:30 PMUSA: Findings from a phase IIa trial revealed a significant reduction in weight and HbA1c (-3.26% and -1.02% placebo-adjusted change with 90 mg,...
Daily oral orforglipron leads to significant weight loss in obese/overweight people: NEJM Medha Baranwal30 Jun 2023 2:30 PMUSA: Daily oral orforglipron led to weight loss in adults with obesity, or with overweight plus at least one weight-related coexisting condition, and...
Semaglutide significantly effective for weight loss in teenagers too: NEJM Study Medha Baranwal4 Nov 2022 6:00 AMAustria: Semaglutide is an obesity drug that mimics a hormone called glucagon-like peptide-1 to target areas of the brain that decrease appetite and...
De-intensification of bolus insulin in type 2 diabetes after GLP-1 RA initiation improves blood sugar and aids weight loss Medha Baranwal6 Oct 2022 5:45 AMItaly: Using GLP-1 receptor agonists instead of prandial insulin is a valuable strategy to simplify the basal-bolus (BB) insulin regimen while...
Use of SGLT2 inhibitors reduces risk of dry eye disease: JAMA Dr. Kamal Kant Kohli27 Sept 2022 2:00 PMTAIWAN: According to the researchers of a large retrospective study reported in JAMA Network Open, one advantage of SGLT2 inhibitors in people with...
GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Dr Kartikeya Kohli10 March 2022 5:00 AMChronic kidney disease (CKD) and end-stage kidney disease (ESKD) are contributors to the health burden and are associated with increased mortality and...
